Press Resease

Enzyme Replacement Therapy Market - Global Industry Analysis

Enzyme Replacement Therapy Market: by Enzyme (pegademase, velaglucerase alfa, agalsidase beta, imiglucerase, taliglucerase, laronidase, alglucosidase alfa, and other enzymes), therapeutic condition (Pompe’s disease, Gaucher’s disease, MPS, Fabry’s disease, SCID, and others), Route of administration (oral and parenteral) and End user (hospitals, infusion centers, and others) – Global Industry Perspective Comprehensive Analysis and Forecast, 2019-2025

Published Date: 26-Nov-2019 Category: Healthcare Report Format : PDF Pages: 130 Report Code: ZMR-5094 Status : Published

Global demand for Enzyme Replacement Therapy Market was valued at approximately USD 6462.6 Million in 2018, and is expected to generate revenue of around USD 9581.64 Million by end of 2025, growing at a CAGR of around 5.81% between 2018 and 2025.

Description

The report covers forecast and analysis for the Enzyme Replacement Therapy market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Enzyme Replacement Therapy market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Enzyme Replacement Therapy market on a global level. In order to give the users of this report a comprehensive view on the Enzyme Replacement Therapy market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein enzyme, therapeutic condition, route of administration, end user, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.

Global Enzyme Replacement Therapy Market

According to the report, global demand for Enzyme Replacement Therapy Market was valued at approximately USD 6462.6 Million in 2018, and is expected to generate revenue of around USD 9581.64 Million by end of 2025, growing at a CAGR of around 5.81% between 2018 and 2025.

Enzymes are molecules that perform catalytic functions in the body in various biochemical reactions. Lysosomal Storage Disease (LSD) is caused by enzyme deficiency in the body and leads to body organs dysfunction. Enzyme replacement therapy for patients suffering from enzyme deficiency is the method of replacing enzymes with artificial enzymes. The therapy is performed by intravenous infusion or oral administration of the preparation-containing enzyme. Enzyme replacement therapies are intended to increase enzyme concentration, but not to alter the underlined root of the diseases. Enzyme replacement therapy for diseases such as Hunter syndrome, Fabry disease, digestive diseases, and Gaucher disorder is currently available

The study provides a decisive view on the Enzyme Replacement Therapy market by segmenting the market based on Enzyme, therapeutic condition, route of administration, end user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on Enzyme, the market is segmented into pegademase, velaglucerase alfa, agalsidase beta, imiglucerase, taliglucerase, laronidase, alglucosidase alfa, and other enzymes. One of the key factors for the large market share of enzymes such as imiglucerase and velaglucerase alfa is the highest incidence of Gaucher disease. For the diagnosis of exocrine pancreatic insufficiency (EPI) typically seen in cancer patients, increased use of pancreatic enzymes such as amylase, lipase, and protease is used. About 55,440 people were expected to be diagnosed with pancreatic cancer in 2018, according to figures from the American Cancer Society. It is therefore predicted that an increased incidence of pancreatic cancer would drive market growth during the forecast period.

Based on the therapeutic condition, the market is bifurcated Pompe’s disease, Gaucher’s disease, MPS, Fabry’s disease, SCID, and others. Gaucher's disease has a high incidence due to its large market share. Gaucher disease is a disease caused by recessive mutation that is inherited. According to United States estimates The disease is estimated to occur in one person in the general population in 50,000 to 100,000 individuals, depending on the location.

Based on the route of administration segment, the market is bifurcated into oral and parenteral. Due to its ability to promote rapid absorption and drug delivery, the parenteral route of administration held the largest market share in 2018. A large number of market players offer a wide range of parenteral enzyme replacement therapy; thus, during the forecast period this segment is expected to witness the highest CAGR.

Based on the end user segment, the market is bifurcated into hospitals, infusion centers, and others. Hospitals are the primary care facilities for a wide range of diseases which promote quick diagnosis. These end-use settings therefore held the largest market share due to frequent patient visits and their ability to cater for a variety of lysosomal storage diseases. During the forecast period, infusion centers are expected to gain the highest CAGR. Since these centers are specialized centers for IV infusions, they facilitate a wide range of inherited diseases for easy treatment. Specialized workers administer infusions at home to improve the experience of patients in some cases.

The geographical segmentation comprises the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market was dominated by North America in 2018. Well-developed healthcare infrastructure and the emergence of North America's leading market players have guided regional segment growth. In addition, it is expected that the adoption of advanced technologies and increased focus on drug development in this region will drive growth in the sector.

The global market for enzyme replacement therapy is probable to experience high growth over the forecast period due to factors such as wider therapy availability, ease of enzyme replacement therapy approval guidelines, and advantages such as fewer side effects. Factors such as easy access to enzyme replacement therapy and government treatment funding are also expected to drive market growth. Reimbursement issues in different countries, however, and less side effects of therapy can impact the progress of enzyme replacement therapy significantly.

Key players within global Enzyme Replacement Therapy market include Sanofi, Shire, Alexion, Pfizer, Digestive Care, Leadiant Biosciences Allergan, BioMarin, AbbVie, Horizon Pharma, Johnson & Johnson Actelion, Recordati Rare Diseases, amongst others.

The report segments global Enzyme Replacement Therapy market as follows:

Global Enzyme Replacement Therapy Market: Enzyme Segment Analysis

  • Imiglucerase
  • Agalsidase Beta
  • Taliglucerase
  • Velaglucerase Alfa
  • Laronidase
  • Alglucosidase Alfa
  • Others

Global Enzyme Replacement Therapy Market: Therapeutic Condition Segment Analysis

  • Gaucher Disease
  • Fabry Disease
  • Pompe Disease
  • SCID
  • MPS
  • Others

Global Enzyme Replacement Therapy Market: Route of Administration Segment Analysis

  • Oral
  • Parenteral

Global Enzyme Replacement Therapy Market: End user Segment Analysis

  • Hospitals
  • Infusion Centers
  • Others

 Global Enzyme Replacement Therapy Market: Regional Segment Analysis

  • North America
    • U.S.
  • Europe
    • UK
    • France
    • Germany
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East and Africa

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodology
      • 1.3.1. Market Research Process
      • 1.3.2. Market Research Methodology
  • Chapter 2. Executive Summary
    • 2.1. Enzyme Replacement Therapy Market, 2016 - 2025, (USD Million)
    • 2.2. Enzyme Replacement Therapy Market: Snapshot
  • Chapter 3. Global Enzyme Replacement Therapy Market - Industry Analysis
    • 3.1. Enzyme Replacement Therapy Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Wider availability of Therapy
    • 3.3. Restraints
      • 3.3.1. Fewer side effects of the therapy
    • 3.4. Opportunity
      • 3.4.1. Exploring new disease indications
    • 3.5. Porter's Five Forces Analysis
    • 3.6. Market Attractiveness Analysis
      • 3.6.1. Market attractiveness analysis by Enzyme Segment
      • 3.6.2. Market attractiveness analysis by Therapeutic condition Segment
      • 3.6.3. Market attractiveness analysis by Route of administration Segment
      • 3.6.4. Market attractiveness analysis by End user segment
      • 3.6.5. Market attractiveness analysis by regional segment
  • Chapter 4. Global Enzyme Replacement Therapy Market - Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Enzyme Replacement Therapy market: company market share analysis, 2018
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New product launches
      • 4.2.3. Agreements, partnerships, collaborations and joint ventures
      • 4.2.4. Research and development and regional expansion
  • Chapter 5. Global Enzyme Replacement Therapy Market - Enzyme Segment Analysis
    • 5.1. Global Enzyme Replacement Therapy market overview: by Enzyme
      • 5.1.1. Global Enzyme Replacement Therapy market revenue share, by Enzyme, 2018 and 2025
    • 5.2. Imiglucerase
      • 5.2.1. Global Enzyme Replacement Therapy market by Imiglucerase, 2016-2025 (USD Million)
    • 5.3. Agalsidase Beta
      • 5.3.1. Global Enzyme Replacement Therapy market by Agalsidase Beta, 2016-2025 (USD Million)
    • 5.4. Taliglucerase
      • 5.4.1. Global Enzyme Replacement Therapy market by Taliglucerase, 2016-2025 (USD Million)
    • 5.5. Velaglucerase Alfa
      • 5.5.1. Global Enzyme Replacement Therapy market by Velaglucerase Alfa, 2016-2025 (USD Million)
    • 5.6. Laronidase
      • 5.6.1. Global Enzyme Replacement Therapy market by Laronidase, 2016-2025 (USD Million)
    • 5.7. Alglucosidase Alfa
      • 5.7.1. Global Enzyme Replacement Therapy market by Alglucosidase Alfa, 2016-2025 (USD Million)
    • 5.8. Other Enzymes
      • 5.8.1. Global Enzyme Replacement Therapy market by Other Enzymes, 2016-2025 (USD Million)
  • Chapter 6. Global Enzyme Replacement Therapy Market - Therapeutic Condition Segment Analysis
    • 6.1. Global Enzyme Replacement Therapy market overview: by Therapeutic Condition
      • 6.1.1. Global Enzyme Replacement Therapy market revenue share, by Therapeutic Condition, 2018 and 2025
    • 6.2. Gaucher Disease
      • 6.2.1. Global Enzyme Replacement Therapy market by Gaucher Disease, 2016-2025 (USD Million)
    • 6.3. Fabry Disease
      • 6.3.1. Global Enzyme Replacement Therapy market by Fabry Disease, 2016-2025 (USD Million)
    • 6.4. Pompe Disease
      • 6.4.1. Global Enzyme Replacement Therapy market by Pompe Disease, 2016-2025 (USD Million)
    • 6.5. SCID
      • 6.5.1. Global Enzyme Replacement Therapy market by SCID, 2016-2025 (USD Million)
    • 6.6. MPS
      • 6.6.1. Global Enzyme Replacement Therapy market by MPS, 2016-2025 (USD Million)
    • 6.7. Other
      • 6.7.1. Global Enzyme Replacement Therapy market by Other, 2016-2025 (USD Million)
  • Chapter 7. Global Enzyme Replacement Therapy Market - End user Segment Analysis
    • 7.1. Global Enzyme Replacement Therapy market overview: by End user
      • 7.1.1. Global Enzyme Replacement Therapy market revenue share, by End user, 2018 and 2025
    • 7.2. Hospitals
      • 7.2.1. Global Enzyme Replacement Therapy market by Hospitals, 2016-2025 (USD Million)
    • 7.3. Infusion Centers
      • 7.3.1. Global Enzyme Replacement Therapy market by Infusion Centers, 2016-2025 (USD Million)
    • 7.4. Others End user
      • 7.4.1. Global Enzyme Replacement Therapy market by Other End user, 2016-2025 (USD Million)
  • Chapter 8. Global Enzyme Replacement Therapy Market - Route of administration Segment Analysis
    • 8.1. Global Enzyme Replacement Therapy market overview: by Route of administration
      • 8.1.1. Global Enzyme Replacement Therapy market revenue share, by Route of administration, 2018 and 2025
    • 8.2. Oral
      • 8.2.1. Global Enzyme Replacement Therapy market by Oral, 2016-2025 (USD Million)
    • 8.3. Parenteral
      • 8.3.1. Global Enzyme Replacement Therapy market by Parenteral, 2016-2025 (USD Million)
  • Chapter 9. Global Enzyme Replacement Therapy Market - Regional Analysis
    • 9.1. Global Enzyme Replacement Therapy market overview: by region
      • 9.1.1. Global Enzyme Replacement Therapy market revenue share, by region, 2018 and 2025
    • 9.2. North America
      • 9.2.1. North America Enzyme Replacement Therapy market, by country, 2016-2025 (USD Million)
      • 9.2.2. North America Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
      • 9.2.3. North America Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
      • 9.2.4. North America Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
      • 9.2.5. North America Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.2.6. The U.S.
        • 9.2.6.1. The U.S. Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.2.6.2. U.S. Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.2.6.3. U.S. Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.2.6.4. The U.S. Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.2.7. Rest of North America
        • 9.2.7.1. Rest of North America Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.2.7.2. Rest of North America Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.2.7.3. Rest of North America Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.2.7.4. Rest of North America Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
    • 9.3. Europe
      • 9.3.1. Europe Enzyme Replacement Therapy market, by country, 2016-2025 (USD Million)
      • 9.3.2. Europe Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
      • 9.3.3. Europe Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
      • 9.3.4. Europe Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
      • 9.3.5. Europe Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.3.6. UK
        • 9.3.6.1. UK Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.3.6.2. UK Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.3.6.3. UK Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.3.6.4. UK Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.3.7. France
        • 9.3.7.1. France Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.3.7.2. France Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.3.7.3. France Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.3.7.4. France Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.3.8. Germany
        • 9.3.8.1. Germany Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.3.8.2. Germany Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.3.8.3. Germany Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.3.8.4. Germany Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.3.9. Rest of Europe
        • 9.3.9.1. Rest of Europe Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.3.9.2. Rest of Europe Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.3.9.3. Rest of Europe Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.3.9.4. Rest of Europe Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
    • 9.4. Asia Pacific
      • 9.4.1. Asia Pacific Enzyme Replacement Therapy market, by country, 2016-2025 (USD Million)
      • 9.4.2. Asia Pacific Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
      • 9.4.3. Asia Pacific Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
      • 9.4.4. Asia Pacific Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
      • 9.4.5. Asia Pacific Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.4.6. China
        • 9.4.6.1. China Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.4.6.2. China Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.4.6.3. China Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.4.6.4. China Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.4.7. France
        • 9.4.7.1. Japan Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.4.7.2. Japan Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.4.7.3. Japan Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.4.7.4. Japan Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.4.8. India
        • 9.4.8.1. India Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.4.8.2. India Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.4.8.3. India Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.4.8.4. India Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.4.9. Rest of Asia Pacific
        • 9.4.9.1. Rest of Asia Pacific Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.4.9.2. Rest of Asia Pacific Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.4.9.3. Rest of Asia Pacific Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.4.9.4. Rest of Asia Pacific Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
    • 9.5. Latin America
      • 9.5.1. Latin America Enzyme Replacement Therapy market, by country, 2016-2025 (USD Million)
      • 9.5.2. Latin America Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
      • 9.5.3. Latin America Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
      • 9.5.4. Latin America Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
      • 9.5.5. Latin America Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.5.6. Brazil
        • 9.5.6.1. Brazil Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.5.6.2. Brazil Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.5.6.3. Brazil Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.5.6.4. Brazil Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
      • 9.5.7. Rest of Latin America
        • 9.5.7.1. Rest of Latin America Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
        • 9.5.7.2. Rest of Latin America Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
        • 9.5.7.3. Rest of Latin America Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
        • 9.5.7.4. Rest of Latin America Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
    • 9.6. Middle East & Africa
      • 9.6.1. Middle East and Africa Enzyme Replacement Therapy market, by country, 2016-2025 (USD Million)
      • 9.6.2. Middle East and Africa Enzyme Replacement Therapy market revenue, by Enzyme, 2016-2025 (USD Million)
      • 9.6.3. Middle East and Africa Enzyme Replacement Therapy market revenue, by Therapeutic condition, 2016-2025 (USD Million)
      • 9.6.4. Middle East and Africa Enzyme Replacement Therapy market revenue, by route of administration, 2016-2025 (USD Million)
      • 9.6.5. Middle East and Africa Enzyme Replacement Therapy market revenue, by End user, 2016-2025 (USD Million)
  • 10. Company Profiles
    • 10.1. Sanofi
      • 10.1.1. Overview
      • 10.1.2. Financials
      • 10.1.3. Product Portfolio
      • 10.1.4. Business Strategy
      • 10.1.5. Recent Developments
    • 10.2. Shire
      • 10.2.1. Overview
      • 10.2.2. Financials
      • 10.2.3. Product Portfolio
      • 10.2.4. Business Strategy
      • 10.2.5. Recent Developments
    • 10.3. BioMarin
      • 10.3.1. Overview
      • 10.3.2. Financials
      • 10.3.3. Product Portfolio
      • 10.3.4. Business Strategy
      • 10.3.5. Recent Developments
    • 10.4. AbbVie
      • 10.4.1. Overview
      • 10.4.2. Financials
      • 10.4.3. Product Portfolio
      • 10.4.4. Business Strategy
      • 10.4.5. Recent Developments
    • 10.5. Alexion
      • 10.5.1. Overview
      • 10.5.2. Financials
      • 10.5.3. Product Portfolio
      • 10.5.4. Business Strategy
      • 10.5.5. Recent Developments
    • 10.6. Allergan
      • 10.6.1. Overview
      • 10.6.2. Financials
      • 10.6.3. Product Portfolio
      • 10.6.4. Business Strategy
      • 10.6.5. Recent Developments
    • 10.7. Horizon Pharma
      • 10.7.1. Overview
      • 10.7.2. Financials
      • 11.7.3. Product Portfolio
      • 11.7.4. Business Strategy
      • 10.7.5. Recent Developments
    • 10.8. Johnson & Johnson
      • 10.8.1. Overview
      • 10.8.2. Financials
      • 10.8.3. Product Portfolio
      • 10.8.4. Business Strategy
      • 10.8.5. Recent Developments
    • 10.9. Actelion
      • 10.9.1. Overview
      • 10.9.2. Financials
      • 10.9.3. Product Portfolio
      • 10.9.4. Business Strategy
      • 10.9.5. Recent Developments
    • 10.10. Recordati Rare Diseases
      • 10.10.1. Overview
      • 10.10.2. Financials
      • 10.10.3. Product Portfolio
      • 10.10.4. Business Strategy
      • 10.10.5. Recent Developments
    • 10.11. Pfizer
      • 10.11.1. Overview
      • 10.11.2. Financials
      • 10.11.3. Product Portfolio
      • 10.11.4. Business Strategy
      • 10.11.5. Recent Developments
    • 10.12. Digestive Care
      • 10.12.1. Overview
      • 10.12.2. Financials
      • 10.12.3. Product Portfolio
      • 10.12.4. Business Strategy
      • 10.12.5. Recent Developments
    • 10.13. Leadiant Biosciences
      • 10.13.1. Overview
      • 10.13.2. Financials
      • 10.13.3. Product Portfolio
      • 10.13.4. Business Strategy
      • 10.13.5. Recent Developments

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

HappyClients

Office Address

Corporate Office

Zion Market Research 244 Fifth Avenue, Suite N202 New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll Free No.1-855-465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1-386-310-3803
US/CAN TOLL FREE +1-855-465-4651
Email: sales@zionmarketresearch.com

We Are On Social